Skip to content

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06309017
Enrollment
150
Registered
2024-03-13
Start date
2025-01-07
Completion date
2027-07-01
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Brief summary

This study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition improves surgical outcomes. The primary objective is to assess whether preoperative malnutrition screening and intervention minimize postoperative complications. The secondary objective is to evaluate whether immune modulation nutrition in the peri-operative period decreases length of stay and major complications.

Interventions

OTHERNutrition specialist

Nutrition specialist to help improve nutritional status by diet, oral nutrition supplements or parenteral nutrition.

DIETARY_SUPPLEMENTEnsure Surgery Immunonutrition shakes

All study subjects, including subjects without malnutrition, will be given the Ensure Surgery Immunonutrition Shakes for prior to surgery as per standard of care. All subjects will also receive additional shakes starting as an inpatient when diet is advanced.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Able and willing to provide written informed consent 2. Aged 18 years of age or older 3. Confirmed diagnosis of inflammatory bowel disease 4. Scheduled for disease-related intestinal resection at NYU Langone Health

Exclusion criteria

1. No current diagnosis of inflammatory bowel disease 2. Age less than 18 3. Not proficient (able to read and answer questions) in English

Design outcomes

Primary

MeasureTime frameDescription
Length of hospital stayUp to 30 days post-surgeryFrom the time the patient is admitted at hospital for surgery until the patient is discharged.
Proportion of patients who experienced postoperative major complicationsVisit 3 (30 days post-surgery)Major complications include infection, bleeding (requiring blood transfusion or requiring intervention), cardiac event (myocardial infarction, arrhythmia, and cardiac arrest), stroke, acute kidney injury (increase in serum creatinine of ≥0.3 mg/dL from baseline or ≥1.5 times baseline), venous thromboembolism, reoperation, readmission, and need for ICU-level care. The outcome measure will be obtained from the electronic health record (EHR).

Secondary

MeasureTime frameDescription
Proportion of patients who participated in a nutritional intervention program before surgeryVisit 3 (30 days post-surgery)
Proportion of patients who participated in a nutritional intervention program after surgeryVisit 3 (30 days post-surgery)
Number of nutritional shakes completedVisit 3 (30 days post-surgery)
Percentage of nutritional shakes completed overallVisit 3 (30 days post-surgery)
Percentage of nutritional shakes completed pre-surgeryOne day prior to surgerySubject will be called the day prior to surgery to determine the number of shakes consumed by patient.
Percentage of nutritional shakes completed post-surgeryOne week post surgeryOne week after surgery, a phone call will follow to determine how many shakes subject consumed.
Proportion of patients who experienced any postoperative complicationsVisit 3 (30 days post-surgery)
Proportion of patients with 30 day readmissionUp to 30 days post-surgery

Countries

United States

Contacts

CONTACTJennifer Katz, MD
Jennifer.katz@nyulangone.org(855) 698-4232
PRINCIPAL_INVESTIGATORJennifer Katz, MD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026